ATE89558T1 - 3(2h)-pyridazinonderivate, verfahren und zwischenprodukte zu deren herstellung und diese und/oder andere 3(2h)-pyridazinonderivate enthaltende heilmittel. - Google Patents

3(2h)-pyridazinonderivate, verfahren und zwischenprodukte zu deren herstellung und diese und/oder andere 3(2h)-pyridazinonderivate enthaltende heilmittel.

Info

Publication number
ATE89558T1
ATE89558T1 AT86115076T AT86115076T ATE89558T1 AT E89558 T1 ATE89558 T1 AT E89558T1 AT 86115076 T AT86115076 T AT 86115076T AT 86115076 T AT86115076 T AT 86115076T AT E89558 T1 ATE89558 T1 AT E89558T1
Authority
AT
Austria
Prior art keywords
group
pyridazinone derivatives
optionally substituted
stands
chem
Prior art date
Application number
AT86115076T
Other languages
English (en)
Inventor
Endre Dr Kasztreiner
Gyoergy Dr Rabloczky
Nandor Dr Makk
Laszlo Dr Jaszlits
Peter Dr Matyus
Gyoergy Dr Cseh
Geb Rapp Ildiko Pribusz
Klara Czako
Eszter Diesler
Istvan Dr Elekes
Laszlo Kaufer
Geb Kuerthy Maria Kuhar
Judit Kincsessy
Judit Dr Kosary
Gyoengyi Geb Csokas Nagy
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Application granted granted Critical
Publication of ATE89558T1 publication Critical patent/ATE89558T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/08—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/12—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/20—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT86115076T 1985-10-30 1986-10-30 3(2h)-pyridazinonderivate, verfahren und zwischenprodukte zu deren herstellung und diese und/oder andere 3(2h)-pyridazinonderivate enthaltende heilmittel. ATE89558T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU854155A HU195645B (en) 1985-10-30 1985-10-30 Process for preparing novel 3(2h)-pyridazinone derivatives and pharmaceutical compositions comprising the same
EP86115076A EP0220735B1 (de) 1985-10-30 1986-10-30 3(2H)-Pyridazinonderivate, Verfahren und Zwischenprodukte zu deren Herstellung und diese und/oder andere 3(2H)-Pyridazinonderivate enthaltende Heilmittel

Publications (1)

Publication Number Publication Date
ATE89558T1 true ATE89558T1 (de) 1993-06-15

Family

ID=10967128

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86115076T ATE89558T1 (de) 1985-10-30 1986-10-30 3(2h)-pyridazinonderivate, verfahren und zwischenprodukte zu deren herstellung und diese und/oder andere 3(2h)-pyridazinonderivate enthaltende heilmittel.

Country Status (9)

Country Link
US (1) US4826845A (de)
EP (1) EP0220735B1 (de)
JP (1) JPS62161768A (de)
AT (1) ATE89558T1 (de)
AU (1) AU589698B2 (de)
CA (1) CA1317598C (de)
DE (1) DE3688450T2 (de)
ES (1) ES2058054T3 (de)
HU (1) HU195645B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE62890B1 (en) * 1988-12-06 1995-03-08 Hafslund Nycomed Pharma New piperazinylalkyl-3(2h)-pyridazinones process for the preparation thereof and the use thereof as agents lowering blood pressure
GB9015764D0 (en) * 1990-07-18 1990-09-05 Fujisawa Pharmaceutical Co Pyrazolopyridine compound and processes for preparation thereof
CN1038249C (zh) * 1991-08-28 1998-05-06 罗姆和哈斯公司 含有二氢哒嗪酮及其相关化合物的杀菌组合物
HU224067B1 (hu) * 1995-05-29 2005-05-30 Gyógyszerkutató Intézet Kft. 3(2H)-Piridazinon-származékok és e vegyületeket tartalmazó gyógyszerkészítmények
JPH11508267A (ja) * 1995-06-26 1999-07-21 藤沢薬品工業株式会社 ピラゾール化合物および医薬組成物
US6447821B1 (en) * 1996-05-30 2002-09-10 Warner-Lambert Company Sugar coated products and process for preparing the same

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT204560B (de) 1957-12-14 1959-07-25 Chemie Linz Ag Verfahren zur Herstellung von neuen Pyridazinderivaten
US2938902A (en) 1959-04-24 1960-05-31 American Cyanamid Co Novel pyridazinones and methods of preparing same
FR5027M (de) * 1966-01-25 1967-04-24
US3658814A (en) * 1970-03-17 1972-04-25 Sandoz Ag 2-(omega-chloroalkyl)-6-aryl substituted-4 5-dihydropyridazin(2h)-3-one
BE752074A (en) * 1970-06-16 1970-12-16 Sandoz Sa Antiinflammatory pyridazines
BE791098A (fr) * 1971-11-10 1973-05-08 Sandoz Sa Nouveaux derives de la pyridazine, leur preparation et leur applicationcomme medicaments
US4304777A (en) * 1979-08-30 1981-12-08 Sterling Drug Inc. 6-(Pyridinyl)-3(2H)-pyridazinones and their use as cardiotonics
US4298609A (en) * 1979-08-30 1981-11-03 Sterling Drug Inc. 4,5-Dihydro-6-(4-pyridinyl)-3-pyridazinol and salts, their preparation and use as blood pressure lowering agents
JPS5728054A (en) * 1980-07-29 1982-02-15 Morishita Seiyaku Kk Pyridazinone derivative
JPS5742676A (en) * 1980-08-29 1982-03-10 Morishita Seiyaku Kk Pyridazinone derivative
JPS58146571A (ja) * 1982-02-25 1983-09-01 Morishita Seiyaku Kk ウレア誘導体およびその製造法
DE3302021A1 (de) * 1983-01-22 1984-07-26 Basf Ag, 6700 Ludwigshafen 6-aryl-4,5-dihydro-3(2h)-pyridazinone, ihre herstellung und verwendung
US4521416A (en) * 1983-03-22 1985-06-04 Warner-Lambert Company 4,5-Dihydro-6-[(substituted)-1H-imidazol-4-yl or 5-yl]-3(2H)-pyridazinones and 6-[(substituted)-1H-imidazol-4-yl or 5-yl]-3(2H)-pyridazinones
US4666902A (en) * 1983-06-20 1987-05-19 Cassella Aktiengesellschaft Tetrahydropyridazinone derivatives, processes for their preparation and their use

Also Published As

Publication number Publication date
US4826845A (en) 1989-05-02
HU195645B (en) 1988-06-28
EP0220735A3 (en) 1988-06-15
JPS62161768A (ja) 1987-07-17
CA1317598C (en) 1993-05-11
EP0220735A2 (de) 1987-05-06
ES2058054T3 (es) 1994-11-01
JPS641475B2 (de) 1989-01-11
HUT43047A (en) 1987-09-28
AU6449686A (en) 1987-05-07
AU589698B2 (en) 1989-10-19
DE3688450D1 (de) 1993-06-24
EP0220735B1 (de) 1993-05-19
DE3688450T2 (de) 1993-09-09

Similar Documents

Publication Publication Date Title
AU577802B2 (en) Blood-pressure lowering piperazine derivatives
ATE38661T1 (de) Zwischenprodukt und verfahren zu dessen herstellung.
DE3177239D1 (de) 4-brommethyl-5-methyl-1,3-dioxolen-2 -on und verfahren zu seiner herstellung.
DE3676179D1 (de) N-enthaltende heterozyklische verbindungen, verfahren zu deren herstellung und diese enthaltende arzneimittel.
DE3166213D1 (en) Carboxamides, their preparation and their use as medicines
ATE89558T1 (de) 3(2h)-pyridazinonderivate, verfahren und zwischenprodukte zu deren herstellung und diese und/oder andere 3(2h)-pyridazinonderivate enthaltende heilmittel.
ATE91682T1 (de) Alkansulfonanilid-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung.
ATE108440T1 (de) Arylaralkylether, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung.
HUT37792A (en) Process for production of derivatives of beta-carbolin-3-carbonic acid and medical preparatives containing such compounds
ATE67199T1 (de) Benzoxazin-derivate und verfahren zu ihrer herstellung.
DE3480839D1 (de) Benzimidazol-derivat, verfahren zu seiner herstellung und pharmazeutische zusammensetzung.
ATE27606T1 (de) 7-alpha-acylthio-15,16-methylen-3-oxo-17-alphapregna-1,4-dien-21,17-carbolaktone, verfahren zu deren herstellung und verwendung in arzneimitteln.
ATE48276T1 (de) 1,6-naphthyridin-derivate, verfahren zu deren herstellung und diese enthaltende arzneimittel.
ATE18667T1 (de) Aethenylimidazol-derivate, verfahren zu deren herstellung und deren pharmazeutische zusammensetzungen, bei deren herstellung verwendbare zwischenprodukte und verfahren zu deren herstellung.
ATE35133T1 (de) N-substituierte (bis(hydroxymethyl)-methyl>isochinolinderivate, verfahren zu ihrer herstellung und pharmazeutische zubereitungen, die sie enthalten.
ES8303393A1 (es) Un procedimiento para preparar derivados del acido ascorbico.
ATE72429T1 (de) Phenoxyessigsaeure-derivate und verfahren zu deren herstellung.
DE3887579D1 (de) Mercapto-substituierte Pyridine und Verfahren zu deren Herstellung.
EP0073345A3 (de) Sydnonimin-Derivate, Verfahren zu deren Herstellung und deren Verwendung
ATE52509T1 (de) Thiazolidinderivate und verfahren zu ihrer herstellung.
ATE34740T1 (de) (bis(hydroxymethyl)methyl)-isochinolinderivate, verfahren zu ihrer herstellung und pharmazeutische zubereitungen, die sie enthalten.
JPS57131777A (en) Preparation of piperazine derivative
HUT47923A (en) Process for production of new derivatives of naphtotiazephin and medical compositions containing these substances
ATE43606T1 (de) Verbindungen mit cardiotropischer aktivitaet, verfahren zu ihrer herstellung und die sie enthaltenden pharmazeutischen zusammensetzungen.
ATE11770T1 (de) N,n,disubstituierte alkenamide und phenylaldenamide, verfahren zu deren herstellung und deren verwendung als pharmazeutika.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee